ABBOTINDIA 27601.00 -194.60(-0.70%)
ADANIGREEN 1940.90 -7.80(-0.40%)
ADANIPORTS 1404.95 -23.65(-1.66%)
AMBUJACEM 605.00 -14.70(-2.37%)
APOLLOHOSP 7068.70 +35.40(0.50%)
ASHOKLEY 235.80 -0.15(-0.06%)
ASIANPAINT 3302.45 +28.25(0.86%)
ASTRAL 1897.55 +1.90(0.10%)
AUBANK 736.00 +12.60(1.74%)
AUROPHARMA 1514.25 -24.50(-1.59%)
AXISBANK 1240.95 +2.60(0.21%)
BAJAJ-AUTO 11873.45 +107.30(0.91%)
BAJAJFINSV 1892.85 +5.35(0.28%)
BAJAJHLDNG 10782.70 +413.55(3.99%)
BAJFINANCE 7583.25 -49.00(-0.64%)
BANDHANBNK 210.00 -3.10(-1.45%)
BANKBARODA 234.80 -2.95(-1.24%)
BERGEPAINT 621.55 +1.60(0.26%)
BHARATFORG 1560.85 -15.45(-0.98%)
BHARTIARTL 1670.15 +17.50(1.06%)
BOSCHLTD 34394.00 -310.00(-0.89%)
BPCL 326.65 -9.25(-2.75%)
BRITANNIA 6204.30 +83.25(1.36%)
CHOLAFIN 1589.50 +1.70(0.11%)
CIPLA 1653.00 +1.10(0.07%)
COALINDIA 478.70 -8.15(-1.67%)
COFORGE 6903.75 +44.50(0.65%)
COLPAL 3628.25 -4.45(-0.12%)
CONCOR 905.40 -22.05(-2.38%)
CUMMINSIND 3664.50 -99.00(-2.63%)
DABUR 659.95 +5.75(0.88%)
DIVISLAB 5450.30 -18.00(-0.33%)
DMART 5196.55 -69.55(-1.32%)
DRREDDY 6546.05 -22.20(-0.34%)
DLF 839.15 -21.45(-2.49%)
EICHERMOT 4864.50 +14.25(0.29%)
FEDERALBNK 182.80 -2.95(-1.59%)
GAIL 210.50 -7.25(-3.33%)
GODREJCP 1441.10 +8.00(0.56%)
GODREJPROP 2821.45 -63.80(-2.21%)
GRASIM 2723.45 -0.80(-0.03%)
HAVELLS 1991.80 +3.10(0.16%)
HDFCAMC 4332.30 -98.90(-2.23%)
HDFCBANK 1710.25 +15.90(0.94%)
HDFCLIFE 703.70 +4.70(0.67%)
HEROMOTOCO 6015.00 +50.20(0.84%)
HCLTECH 1733.70 -21.95(-1.25%)
HINDALCO 676.20 -8.90(-1.30%)
HINDPETRO 398.55 -8.75(-2.15%)
HINDUNILVR 2922.15 +45.70(1.59%)
ICICIBANK 1290.00 +1.95(0.15%)
ICICIGI 2173.65 +32.80(1.53%)
ICICIPRULI 758.05 +6.70(0.89%)
IDEA 10.59 -2.32(-17.97%)
IDFCFIRSTB 72.56 -0.22(-0.30%)
INDHOTEL 677.50 -3.80(-0.56%)
INDUSINDBK 1485.80 +6.20(0.42%)
INFY 1887.00 -5.35(-0.28%)
ITC 509.30 +2.25(0.44%)
JSWSTEEL 947.20 -8.40(-0.88%)
JUBLFOOD 677.15 +1.95(0.29%)
KOTAKBANK 1856.40 +17.35(0.94%)
LT 3685.70 -43.95(-1.18%)
LTTS 5515.70 +39.25(0.72%)
LUPIN 2170.35 -54.00(-2.43%)
M&M 2799.15 -9.65(-0.34%)
MARICO 692.70 -3.15(-0.45%)
MARUTI 12373.95 +173.75(1.42%)
MPHASIS 2966.20 -40.85(-1.36%)
MRF 134932.05 +730.80(0.54%)
MUTHOOTFIN 2046.20 +27.90(1.38%)
NAUKRI 7805.90 +64.15(0.83%)
NESTLEIND 2647.95 +53.20(2.05%)
NMDC 210.10 -2.15(-1.01%)
NTPC 423.45 +9.60(2.32%)
ONGC 284.65 -5.45(-1.88%)
PAGEIND 42850.05 -136.60(-0.32%)
PEL 1044.20 -36.85(-3.41%)
PERSISTENT 5218.50 +40.95(0.79%)
PGHH 16638.20 +73.90(0.45%)
PIDILITIND 3207.85 +17.15(0.54%)
PIIND 4674.00 +19.35(0.42%)
PNB 106.70 -2.00(-1.84%)
PNBHOUSING 1010.20 -65.80(-6.12%)
POLYCAB 6501.95 -161.85(-2.43%)
POWERGRID 333.20 -1.00(-0.30%)
RELIANCE 2941.05 +14.80(0.51%)
SBICARD 784.20 +4.70(0.60%)
SBILIFE 1838.40 -4.30(-0.23%)
SBIN 786.95 -5.40(-0.68%)
SHREECEM 24795.95 -220.05(-0.88%)
SIEMENS 6560.35 -174.90(-2.60%)
SRF 2388.80 +0.15(0.01%)
SUNPHARMA 1860.25 -5.65(-0.30%)
TATACONSUM 1214.60 +13.95(1.16%)
TATACHEM 1002.00 -15.45(-1.52%)
TATAMOTORS 957.90 -4.50(-0.47%)
TATAPOWER 433.95 -6.70(-1.52%)
TATASTEEL 148.60 -2.00(-1.33%)
TCS 4289.75 -56.85(-1.31%)
TECHM 1596.80 -8.55(-0.53%)
TITAN 3768.75 +45.10(1.21%)
TORNTPHARM 3329.90 -30.45(-0.91%)
TTML 85.84 -2.51(-2.84%)
ULTRACEMCO 11600.00 -33.55(-0.29%)
UBL 2122.60 +73.60(3.59%)
UPL 588.65 -16.20(-2.68%)
VEDL 445.15 -3.00(-0.67%)
VOLTAS 1912.70 +22.60(1.20%)
WIPRO 531.15 -6.65(-1.24%)
YESBANK 22.89 -0.41(-1.76%)
ZEEL 127.00 -4.25(-3.24%)
ZYDUSLIFE 1047.70 -31.65(-2.93%)

The Impact of Global Events of Foriegn Investments on 16 Jul 2024

Image is loading
Image is loadingImage is loading
Foreign Investment(buy/sell) Trends of 16 Jul 2024: Global Events on Vijaya Diagnostic Centre Limited, Manomay Tex India Limited

Comapny Logo Company Client name Buy/Sell Qty Traded Price Trader Name
Vijaya Diagnostic Centre Limited Al Mehwar Commercial Investments L.l.c. SELL 594K 775.03 Na
Manomay Tex India Limited Nav Capital Vcc – Nav Capital Emerging Star Fund BUY 99K 203.36 Na

The 594K shares of Vijaya Diagnostic Centre Limited have been sold by the by Al Mehwar Commercial Investments L.l.c. through Foriegn Investments at a price of ₹775.03 per share.
The 99K shares of Manomay Tex India Limited have been purchased by the by Nav Capital Vcc – Nav Capital Emerging Star Fund through Foriegn Investments at a price of ₹203.36 per share.

Company Logo Company Client name Buy/Sell Qty Traded Price Trader Name
Zomato Limited Bnp Paribas Arbitrage BUY 735K 226.85 Motilal Oswal Mutual Fund
Zomato Limited Citigroup Global Markets Mauritius Private Limited (odi) BUY 1M 226.85 Motilal Oswal Mutual Fund
Zomato Limited Goldman Sachs Investments (mauritius) I Limited Short Term BUY 920K 226.85 Motilal Oswal Mutual Fund
Zomato Limited Matthews Asia Funds Pacific Tiger Fund BUY 90K 226.85 Motilal Oswal Mutual Fund
Zomato Limited Matthews Pacific Tiger Fund BUY 558K 226.85 Motilal Oswal Mutual Fund
Zomato Limited Morgan Stanley Asia Singapore Pte BUY 440K 226.85 Motilal Oswal Mutual Fund
Zomato Limited Motilal Oswal Mutual Fund SELL 28M 226.85 Axis Mutual Fund A/c Axis Focused 25 Fund
Zomato Limited Optimas Global Alpha Fund BUY 735K 226.85 Motilal Oswal Mutual Fund
Zomato Limited Polar Capital Funds Plc-global Technology Fund BUY 6M 226.85 Motilal Oswal Mutual Fund
Zomato Limited Societe Generale BUY 12M 226.85 Motilal Oswal Mutual Fund

Zomato Limited shares totaling 735K were purchased by the by Bnp Paribas Arbitrage of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share. Zomato Limited shares totaling 1M were purchased by the by Citigroup Global Markets Mauritius Private Limited (odi) of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share. Zomato Limited shares totaling 920K were purchased by the by Goldman Sachs Investments (mauritius) I Limited Short Term of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share.
Zomato Limited shares totaling 90K were purchased by the by Matthews Asia Funds Pacific Tiger Fund of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share. Zomato Limited shares totaling 558K were purchased by the by Matthews Pacific Tiger Fund of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share. Zomato Limited shares totaling 440K were purchased by the by Morgan Stanley Asia Singapore Pte of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share.
Zomato Limited shares totaling 28M were sold by the by Motilal Oswal Mutual Fund of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were purchased by Axis Mutual Fund A/c Axis Focused 25 Fund at the same price per share. Zomato Limited shares totaling 735K were purchased by the by Optimas Global Alpha Fund of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share. Zomato Limited shares totaling 6M were purchased by the by Polar Capital Funds Plc-global Technology Fund of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share.
Zomato Limited shares totaling 12M were purchased by the by Societe Generale of Foriegn Investments, with the transaction occurring at a price of ₹226.85 per share. Subsequently, the shares were sold by Motilal Oswal Mutual Fund at the same price per share.

Vijaya Diagnostic Centre Limited

1,562.17

Net Sales

315.05

Net Profit

1,597.81

Total Income

1,178.79

Expenditure

920

Current Price

9,437

Market Cap



The financial snapshot for Vijaya Diagnostic Centre Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹1,562.17 million and total income was ₹1,597.81 million. The company's expenditure was ₹1,178.79 million, leading to a net profit of ₹315.05 million. Earnings per Share (EPS) for continuing operations were ₹3.06. The report also highlights other income of ₹35.64 million, finance costs of ₹62.65 million, and employee benefit expenses of ₹273.58 million. Depreciation and amortization costs were ₹166.34 million, while current and deferred taxes were ₹96.09 million and ₹7.88 million, respectively. The total comprehensive income for the period stood at ₹314.71 million, with other comprehensive income net of taxes at ₹-0.34 million.

With a market capitalization of ₹9,437 crore, the company’s stock is currently priced at ₹920. The historical trading range of the stock is ₹965 / 453. The P/E ratio is remarkably high at 75.2, suggesting a significant valuation. The book value stands at ₹64.2, and the dividend yield is 0.11%. The Return on Capital Employed (ROCE) is 19.5%, and the Return on Equity (ROE) is 17.8%. The debt-to-equity ratio is very low at 0.39, though the company shows a negative net cash flow of ₹-1.93 crore. The Piotroski score is 6.00, with the Graham Number pegged at ₹132. The Price-to-Book (P/B) ratio of 14.3 highlights a premium valuation.

Manomay Tex India Limited

1,553.92

Net Sales

51.08

Net Profit

1,554.60

Total Income

1,486.29

Expenditure

211

Current Price

384

Market Cap



In the most recent financial analysis for Manomay Tex India Limited, key metrics demonstrate a solid performance. The net sales reached ₹1,553.92 million, with total income amounting to ₹1,554.60 million. Expenditure was recorded at ₹1,486.29 million, resulting in a net profit of ₹51.08 million. EPS figures for continuing operations are ₹2.83. Other notable figures include other income of ₹0.69 million, finance costs of ₹52.30 million, and employee benefit expenses totaling ₹85.87 million. Depreciation and amortization expenses were ₹76.34 million, with current tax at ₹18.00 million and deferred tax at ₹-0.77 million. The total comprehensive income for the period was ₹51.04 million, and other comprehensive income net of taxes was ₹-0.04 million.

The company's market cap is ₹384 crore, with a stock price of ₹211. The historical stock range has been between ₹228 / 116. Its Price-to-Earnings (P/E) ratio of 29.6 indicates a high valuation. The book value per share is ₹71.5, and it has a dividend yield of 0.00%. The ROCE is 10.1% and ROE is 10.6%. With a very low debt-to-equity ratio of 2.32, the company is minimally leveraged. However, it reports a negative net cash flow of ₹-13.0 crore. The Piotroski score of 4.00 and the Graham Number of ₹108 show mixed financial indicators, while the Price-to-Book (P/B) ratio of 2.95 suggests the stock is trading at a premium.

Zomato Limited

20,480.00

Net Sales

4,700.00

Net Profit

23,270.00

Total Income

18,540.00

Expenditure

263

Current Price

2,32,521

Market Cap



In Zomato Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹20,480.00 million, with total income of ₹23,270.00 million. The expenditure was ₹18,540.00 million, leading to a net profit of ₹4,700.00 million. Earnings per Share (EPS) for continuing operations were reported at ₹0.54. The financial overview also includes other income of ₹2,790.00 million, finance costs of ₹40.00 million, and employee benefit expenses totaling ₹2,820.00 million. Depreciation and amortization expenses were ₹190.00 million. Current and deferred taxes were recorded at ₹0.00 million and ₹0.00 million, respectively. The total comprehensive income for the period was ₹4,820.00 million, and other comprehensive income net of taxes was ₹120.00 million.

With a market capitalization of ₹2,32,521 crore, the company’s stock is currently priced at ₹263. The historical trading range of the stock is ₹281 / 96.5. The P/E ratio is remarkably high at 386, suggesting a significant valuation. The book value stands at ₹23.1, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 1.14%, and the Return on Equity (ROE) is 1.12%. The debt-to-equity ratio is very low at 0.04, though the company shows a negative net cash flow of ₹91.0 crore. The Piotroski score is 7.00, with the Graham Number pegged at ₹18.9. The Price-to-Book (P/B) ratio of 11.4 highlights a premium valuation.

Related Post